NASDAQ: CVKDCadrenal Therapeutics Inc Stock Ownership - Who owns Cadrenal Therapeutics?
Insider buying vs selling
Have Cadrenal Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when CVKD insiders and whales buy or sell their stock.
CVKD Shareholders
What type of owners hold Cadrenal Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Quang X. Pham | 319.07% | 6,275,000 | $86.97M | Insider |
| John Raymond Murphy | 31.26% | 614,792 | $8.52M | Insider |
| Matthew K. Szot | 25.42% | 500,000 | $6.93M | Insider |
| Glynn Wilson | 2.54% | 50,000 | $693.00k | Insider |
| Vanguard Group Inc | 2.32% | 45,633 | $632.47k | Institution |
| Steven Zelenkofske | 2.03% | 40,000 | $554.40k | Insider |
| Geode Capital Management LLC | 0.61% | 12,086 | $167.51k | Institution |
| Ubs Group Ag | 0.43% | 8,445 | $117.05k | Institution |
| Osaic Holdings Inc | 0.08% | 1,500 | $20.79k | Institution |
| Morgan Stanley | 0.06% | 1,130 | $15.66k | Institution |
CVKD vs Biotech Stocks
Cadrenal Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.